Jatenzo 158 MG Oral Capsule

RxCUI: 2201640
RxNorm name: Jatenzo 158 MG Oral Capsule
Display name: Jatenzo 158 MG Oral Capsule
Full name: Jatenzo 158 MG Oral Capsule
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Jatenzo	TESTOSTERONE UNDECANOATE	TOLMAR Inc.	ed7b5d41-7475-4c10-99b9-b62b3434ae60	2025-09-30	Warnings, Adverse reactions	Exact identifier rxcui: 2201640

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
ed7b5d41-7475-4c10-99b9-b62b3434ae60	Jatenzo 158 MG Oral Capsule	SY	12	These highlights do not include all the information needed to use JATENZO ® safely and effectively. See full prescribing information for JATENZO. JATENZO (testosterone undecanoate) capsules, for oral use CIII Initial U.S. Approval: 1953	20250915
ed7b5d41-7475-4c10-99b9-b62b3434ae60	testosterone undecanoate 158 MG Oral Capsule [Jatenzo]	SBD	12	These highlights do not include all the information needed to use JATENZO ® safely and effectively. See full prescribing information for JATENZO. JATENZO (testosterone undecanoate) capsules, for oral use CIII Initial U.S. Approval: 1953	20250915
ed7b5d41-7475-4c10-99b9-b62b3434ae60	JATENZO 158 MG Oral Capsule	PSN	12	These highlights do not include all the information needed to use JATENZO ® safely and effectively. See full prescribing information for JATENZO. JATENZO (testosterone undecanoate) capsules, for oral use CIII Initial U.S. Approval: 1953	20250915